The instrument is the entry ticket, not the cost
For clinical chemistry, the analyzer itself is typically a minority of lifetime spend. Reagents and consumables recur with every run; calibrators and controls recur with every QC cycle; service contracts and spare parts recur annually; and volume commitments attach to reagent contracts regardless of how the instrument was financed. Two suppliers quoting similar list prices can differ severalfold in cost per test once menu breadth and minimum volumes are accounted for.
Three procurement models, three risk allocations
Outright purchase puts utilization risk on the laboratory: low volumes make each test expensive. Reagent rental puts the instrument cost inside a reagent commitment: the lab pays per test, but commits to volumes and often to menu exclusivity for the term. Cost-per-test contracts go further, bundling service and consumables into a single per-reportable-test price. A 2024 peer-reviewed study of public procurement (PMC, 2024) compared bids across these models and reported the maintenance-free reagent-rental bid achieved a 47.4% lower cost per reportable test than the laboratory’s previous purchased-equipment arrangement — evidence that model choice can outweigh hardware choice.
What drives cost per test
Five levers recur across tenders: (1) menu breadth — consolidating assays onto one platform raises reagent utilization and lowers per-test overhead; (2) calibration and QC frequency — systems needing frequent calibration burn more control material; (3) reagent minimums and expiry — unused reagent is paid-for waste; (4) service response terms — downtime costs more than the contract saves; and (5) volume commitments — the discount is real only if the volume is.
Where analyzer prices are actually public
Manufacturers rarely publish list prices, but procurement is increasingly transparent. Government tender portals publish award notices with awarded amounts; aggregator sites such as Tender247 index chemistry-analyzer award results across jurisdictions. In the United States, the VA National Acquisition Center publishes cost-per-test pricelists for analyzer systems under federal supply schedules (vendorportal.ecms.va.gov/nac). China’s volume-based procurement programs have shown how centralized purchasing compresses IVD prices at scale. Awarded prices still need care — they embed volumes, service terms and local conditions — but they are real transactions, not vendor brochure figures.
Comparing suppliers on cost, step by step
Build a per-test model before contacting anyone: list the assays you actually run, the volumes per month, and the reagent/ calibrator/ control consumption each candidate system states in its documentation. Add service terms and amortization, then divide by reportable tests. IVDmap product records carry the published specification fields (throughput, sample types, time to result) with the source page they came from, so the specification comparison can happen before a quote exists; the supplier verification checklist (https://ivdmap.com/insights/how-to-choose-an-ivd-supplier) covers the rest of the evaluation.
